AI-First Biology

Author / investor / scientist Nathan Benaich outlines how drug discovery is being completely reworked by computational approaches. The whole post was great, but the part that resonated most was at the very end—the author compares drug companies to game studios, where the core competitive advantage is the process / technology used to repeatably bring new games (or drugs) to market. Computational biology is an upgrade to that machine.

There were also links to two companies who are doing this right now that I had not heard of before: LabGenius and Recursion.

We're beginning to see what the deployment phase looks like for this round of AI.


Want to receive more content like this in your inbox?